Notably, aberrant and persistent activation of NF-κB may promote tumor progression (49), so that the activity of Fbxo16 to inhibit NF-κB activation, which we demonstrated in this study, might be related to the tumor suppressive function of Fbxo16 described above. The gene discussed is FBXO16; the disease is neoplasm.